Table 2 Linear regression analysis between clinicopathologic characteristics and normalized SLC7 family gene expression in thyroid cancer patients
Gene | Age | Tumor size | Gender (male) | Absence of thyroiditis | Absence of ETE | AJCC stage (III/IV) | BRAF mutation | RAS mutation | Mortality |
|---|---|---|---|---|---|---|---|---|---|
SLC7A1 | ++ | ||||||||
SLC7A2 | − | +++ | |||||||
SLC7A3 | ++ | + | ++ | − | + | ||||
SLC7A4 | +++ | −−− | |||||||
SLC7A5 | + | ||||||||
SLC7A6 | −−− | +++ | |||||||
SLC7A7 | +++ | ||||||||
SLC7A8 | − | −− | −− | + | −− | ||||
SLC7A9 | ++ | − | −−− | ||||||
SLC7A10 | |||||||||
SLC7A11 | − | ||||||||
SLC7A13 | |||||||||
SLC7A14 | − |